MADRIGAL PHARMACEUTICALS INC (MDGL)

US5588681057 - Common Stock

206.92  -1.12 (-0.54%)

After market: 206.92 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
380.50M293.60M242.50M206.70M95.00M
Research and Development
272.35M245.40M205.20M184.80M72.30M
Selling, General, and Administrative Expenses
108.15M48.10M37.30M21.90M22.60M
Operating Income
-380.50M-293.60M-242.50M-206.70M-95.00M
Interest Income/Expense
6.87M-1.80M400.00K4.30M11.00M
Other Income/Expense
0.000.00300.00K100.00K0.00
Income Before Taxes
-373.63M-295.40M-241.80M-202.20M-83.90M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-373.63M-295.40M-241.80M-202.20M-83.90M
EBITDA
-379.97M-293.13M-242.09M-206.23M-94.89M
 
Per Share Data
EPS Diluted Total Ops
-19.99-17.27-14.65-13.12-5.45
Non GAAP EPS
-19.94-17.23-14.61-13.09-5.45
 
Statistics

All data in USD

Charts